Wall Street analysts forecast that Encompass Health Corp (NYSE:EHC) will announce earnings per share of $0.80 for the current quarter, according to Zacks. Six analysts have provided estimates for Encompass Health’s earnings. The highest EPS estimate is $0.85 and the lowest is $0.77. Encompass Health posted earnings per share of $0.70 in the same quarter last year, which would suggest a positive year-over-year growth rate of 14.3%. The firm is expected to announce its next earnings results on Monday, February 25th.
On average, analysts expect that Encompass Health will report full-year earnings of $3.60 per share for the current financial year, with EPS estimates ranging from $3.55 to $3.67. For the next year, analysts anticipate that the business will report earnings of $3.78 per share, with EPS estimates ranging from $3.67 to $4.06. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow Encompass Health.
A number of equities research analysts have issued reports on the company. Piper Jaffray Companies raised Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Credit Suisse Group boosted their price target on Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. Finally, Mizuho reissued a “buy” rating and set a $82.00 price target on shares of Encompass Health in a research report on Thursday, July 26th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $73.00.
EHC stock opened at $70.41 on Friday. Encompass Health has a 12-month low of $47.32 and a 12-month high of $82.46. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 1.58. The stock has a market cap of $6.83 billion, a price-to-earnings ratio of 25.51, a PEG ratio of 1.75 and a beta of 0.49.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Wednesday, January 2nd will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, December 31st. Encompass Health’s payout ratio is 39.13%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: Do Tariffs Work?
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.